TOS/CDC Joint Symposium: Connecting the CORD - Childhood Obesity Research Demonstration (CORD) 3.0 - Part 1
When: Thursday, 11/3/2022, 3:30 pm - 5:00 pm
Where: San Diego Convention Center-30ABCDE
Description: The Centers for Disease Control and Prevention's Childhood Obesity Research Demonstration (CORD) 3.0 funding is designed to enhance access to evidence-based pediatric weight management interventions (PWMIs) for children and families from low-income communities. Each of five funded sites is developing interactive, web-based packages of evidence-based PWMIs to promote high fidelity program implementation across rural and urban, community and clinical settings. This symposium will provide an overview of the CORD 3.0 projects and highlight two examples of the innovative approaches being used by sites to increase access to pediatric obesity treatment, including novel strategies to support identification and referral of families, training providers, and evaluating program/intervention costs. Speakers will review the strategies employed and, as available, share preliminary information related to implementation of procedures.

This session was jointly produced by The Obesity Society (TOS) and the Centers for Disease Control and Prevention (CDC).
Delivery Mechanism: Live In-Person
Keyword: Target Population: Pediatrics/Adolescents; Treatment: Exercise/Physical Activity/Sedentary Behavior Modification
Track: Sub-track: Pediatrics; Track 3: Interventional and Clinical Studies; Track 4: Population Health
Name Role Presentation
Brook Belay Chair Session Chair
Alyson B. Goodman, MD, MPH CME Session Speaker Overview of the CORD 3.0 Initiative
Sarah E. Hampl, MD, FAAP, DiplABOM CME Session Speaker Integrated Digital Platform to Support Implementation of Family-based Behavioral Treatment: Missouri CORD
Thomas Robinson, MD, MPH, FTOS CME Session Speaker Applying the Biodesign Innovation Process to Package and Scale an Evidence-based Pediatric Weight Management Intervention: Stanford CORD
Brook Belay Chair Moderate Panel Q&A
Alyson B. Goodman, MD, MPH CME Session Speaker Panel Q&A
Sarah E. Hampl, MD, FAAP, DiplABOM CME Session Speaker Panel Q&A
Thomas Robinson, MD, MPH, FTOS CME Session Speaker Panel Q&A
Learning Objectives:
1. Apply the latest recommendations for evaluation and treatment; tailor intervention strategies based on patient characteristics such as age or metabolic or behavioral phenotype; understand the differences between weight loss and weight loss maintenance.
2. Understand the evidence-based science regarding neuroendocrine, environmental, endocrine, microbiota and/or cognitive behavioral mechanisms regulating energy balance and body weight. Apply that knowledge to develop and implement treatment options for adults and pediatric patients with overweight, obesity or obesity-related co-morbidities.
3. Implement appropriate strategies for diagnosing adolescent and pediatric obesity, evaluate current treatment options and emerging therapeutics and provide care and treatment to adolescent and pediatric patients accordingly. Teach evidence-based strategies for obesity prevention in the pediatric and adolescent population.